PGEN

PRECIGEN INC

PGEN·74017N105·US·Common Stock·Healthcare - Biotechnology-Activist

PGEN (PRECIGEN INC) is held by 114 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($58.9M), STATE STREET CORP ($42.1M), VANGUARD CAPITAL MANAGEMENT LLC ($27.7M). Net institutional sentiment: Mixed.

114
Holders
Avg rating(25 Elite)
$325.2M
Total Value
61% (117)
Fund Consensus
65 buying - 42 selling
PGENSmart Money Verdict
View all
Held by 114 funds
25 elite
Who's Trading
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.1.9%May 15, 2026
ActivistRJRANDAL J. KIRK35.9%Mar 31, 2026
InsiderKJKIRK RANDAL JSell $3.7MMar 30, 2026
InsiderKJKIRK RANDAL JSell $7.7MMar 30, 2026
InsiderKJKIRK RANDAL JSell $1.4MMar 30, 2026
InsiderKJKIRK RANDAL JSell $1.2MMar 30, 2026
InsiderKJKIRK RANDAL JSell $502KMar 30, 2026
InsiderKJKIRK RANDAL JSell $557KMar 30, 2026
InsiderKJKIRK RANDAL JSell $155KMar 30, 2026
InsiderKJKIRK RANDAL JSell $168KMar 30, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
15.2M(+0.8%)$58.9M0.0%+195.24%
30
Increased
10.9M(+0.6%)$42.1M0.0%+58.50%
29
New
7.1M$27.7M0.0%+57.40%
40
Decreased
6.6M(-51.6%)$25.7M0.0%+28.68%
0
Increased
4.6M(+3.4%)$17.9M0.0%+72.15%
29
Increased
3.4M(+54.1%)$13M0.0%+55.06%
39
Decreased
2.7M(-16.8%)$10.5M0.0%+50.99%
0
Increased
2.6M(+462.7%)$10.2M0.0%+55.85%
45
Decreased
2.4M(-24.4%)$9.3M0.0%+111.61%
0
New
2.1M$8.2M0.0%+57.40%
38
Decreased
2M(-57.0%)$7.7M0.0%+27.36%
0
New
1.8M$7.1M0.0%+57.40%
38
Increased
1.6M(+2.1%)$6.2M0.0%+84.27%
28
Decreased
1.5M(-32.8%)$5.7M0.0%+86.20%
0
Decreased
1.5M(-3.1%)$5.7M0.0%+77.18%
0
Increased
1.4M(+0.0%)$5.4M0.0%+24.89%
27
New
1.2M$4.6M0.0%+57.40%
37
Increased
911,206(+111.1%)$3.5M0.0%+121.77%
43
Unchanged
846,000$3.3M0.0%+446.59%
0
Decreased
793,773(-78.0%)$3.1M0.0%+36.32%
0

Showing 1-20 of 117

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used